carvedilol has been researched along with Proteinuria in 5 studies
Proteinuria: The presence of proteins in the urine, an indicator of KIDNEY DISEASES.
| Excerpt | Relevance | Reference |
|---|---|---|
| " We analyzed whether the use of a new beta adrenoceptor antagonist and vasodilator, carvedilol (CVD), slows the progression of nephrosclerosis and whether the renoprotective effect as well as reduction in cardiac hypertrophy is dependent on the degree of blood pressure reduction." | 7.69 | Effects of the novel multiple-action agent carvedilol on severe nephrosclerosis in renal ablated rats. ( Anabitarte, A; Cabrera, J; Llobet, J; Losada, A; Palop, L; Plaza, C; Rodriguez-Perez, JC, 1997) |
| "Carvedilol was not found to be as effective as ACEIs and AT1ras in decreasing proteinuria and preserving renal function." | 6.73 | Comparison of higher dose of losartan treatment with losartan plus carvedilol and losartan plus ramipril in patients with glomerulonephritis and proteinuria. ( Akdag, I; Arabul, M; Dilek, K; Ersoy, A; Gullulu, M; Kahvecioglu, S; Yavuz, M; Yurtkuran, M, 2007) |
| " We analyzed whether the use of a new beta adrenoceptor antagonist and vasodilator, carvedilol (CVD), slows the progression of nephrosclerosis and whether the renoprotective effect as well as reduction in cardiac hypertrophy is dependent on the degree of blood pressure reduction." | 3.69 | Effects of the novel multiple-action agent carvedilol on severe nephrosclerosis in renal ablated rats. ( Anabitarte, A; Cabrera, J; Llobet, J; Losada, A; Palop, L; Plaza, C; Rodriguez-Perez, JC, 1997) |
| "Carvedilol was not found to be as effective as ACEIs and AT1ras in decreasing proteinuria and preserving renal function." | 2.73 | Comparison of higher dose of losartan treatment with losartan plus carvedilol and losartan plus ramipril in patients with glomerulonephritis and proteinuria. ( Akdag, I; Arabul, M; Dilek, K; Ersoy, A; Gullulu, M; Kahvecioglu, S; Yavuz, M; Yurtkuran, M, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (40.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jovanovic, D | 1 |
| Jovovic, D | 1 |
| Mihailovic-Stanojevic, N | 1 |
| Miloradovic, Z | 1 |
| Naumovic, R | 1 |
| Dimitrijevic, J | 1 |
| Maksic, N | 1 |
| Djukanovic, L | 1 |
| Tylicki, L | 1 |
| Biedunkiewicz, B | 1 |
| Chamienia, A | 1 |
| Wojnarowski, K | 1 |
| Zdrojewski, Z | 1 |
| Aleksandrowicz, E | 1 |
| Lysiak-Szydlowska, W | 1 |
| Rutkowski, B | 1 |
| Kahvecioglu, S | 1 |
| Akdag, I | 1 |
| Gullulu, M | 1 |
| Arabul, M | 1 |
| Ersoy, A | 1 |
| Dilek, K | 1 |
| Yavuz, M | 1 |
| Yurtkuran, M | 1 |
| Brooks, DP | 1 |
| Short, BG | 1 |
| Cyronak, MJ | 1 |
| Contino, LC | 1 |
| DiCristo, M | 1 |
| Wang, YX | 1 |
| Ruffolo, RR | 1 |
| Rodriguez-Perez, JC | 1 |
| Losada, A | 1 |
| Anabitarte, A | 1 |
| Cabrera, J | 1 |
| Llobet, J | 1 |
| Palop, L | 1 |
| Plaza, C | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Renal Transplant Injury and the Renin-Angiotensin System in Kids (RETASK)[NCT03317925] | 29 participants (Actual) | Observational | 2014-07-16 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 trials available for carvedilol and Proteinuria
| Article | Year |
|---|---|
Renal allograft protection with angiotensin II type 1 receptor antagonists.
Topics: Adult; Angiotensin II Type 1 Receptor Blockers; Biomarkers; Carbazoles; Carvedilol; Cross-Over Studi | 2007 |
Comparison of higher dose of losartan treatment with losartan plus carvedilol and losartan plus ramipril in patients with glomerulonephritis and proteinuria.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; C | 2007 |
3 other studies available for carvedilol and Proteinuria
| Article | Year |
|---|---|
Effect of carvedilol on pulse pressure and left ventricular hypertrophy in spontaneously hypertensive rats with adriamycin nephropathy.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Biomarkers; Blood Pressu | 2009 |
Comparison between carvedilol and captopril in rats with partial ablation-induced chronic renal failure.
Topics: Adrenergic beta-Antagonists; Animals; Blood Pressure; Blood Urea Nitrogen; Captopril; Carbazoles; Ca | 1993 |
Effects of the novel multiple-action agent carvedilol on severe nephrosclerosis in renal ablated rats.
Topics: Adrenergic beta-Antagonists; Animals; Blood Pressure; Carbazoles; Carvedilol; Hypertrophy, Left Vent | 1997 |